Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
- PMID: 36173410
- PMCID: PMC9747027
- DOI: 10.1590/S1677-5538.IBJU.2022.06.02
Editorial Comment: Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity
Conflict of interest statement
None declared.
Comment on
-
Solifenacin Treatment After Intradetrusor Injections With Botulinum Toxin in Patients With Neurogenic Detrusor Overactivity.Am J Ther. 2022 Sep-Oct 01;29(5):e507-e511. doi: 10.1097/MJT.0000000000001531. Epub 2022 Jun 21. Am J Ther. 2022. PMID: 35731251
References
-
- Ciofu I, Ceausu I, Chirca NM, Persu C. Solifenacin treatment after intradetrusor injections with botulinum toxin in patients with neurogenic detrusor overactivity. Am J Ther. 2022 Jun 21; Epub ahead of print. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical